Skip to main content

Exclusive interview and HNW content now available on Post Europe

post-europe-the-real-one

Post Europe’s weekly update is now live with an interview with Portuguese broker MDS and a View from The Top on how the Swedish market is embracing fine art.

Jose Manuel Dias da Fonseca, president of Portuguese broker MDS, talks to Post Europe about the Portuguese insurance market, regulation in the European Union and MDS's plans for expansion.

While Markel's Anne-Sofia Hedin explains why the rise of new, wealthier generation, with a renewed interest in fine art, not only as an investment but also as a fashion statement, has led Swedish insurers to reassure their high net worth offerings.

Post is dedicated to the European general insurance market and provides news, analysis, comment and features focused on different territories. To receive your personal update on all the recent European insurance new sign up for Post Europe Alerts.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Could the Gallagher and PIB deal be back on?

Deputy Editor’s View: Whispers at the British Insurance Brokers' Association conference earlier this month suggest Gallagher could be willing to buy PIB again, less than a year after plug was pulled on a deal and the latter refinanced.

Acrisure blames AI for slashing 2250 jobs

Acrisure is cutting around 11% of its global workforce, after chief executive and co-founder Greg Williams told staff advances in artificial intelligence and technology are reshaping how the business operates and serves clients.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here